Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Prospective validation of the EuroSCORE II risk model in a single Dutch cardiac surgery centre.

Hogervorst EK, Rosseel PMJ, van de Watering LMG, Brand A, Bentala M, van der Meer BJM, van der Bom JG.

Neth Heart J. 2018 Nov;26(11):540-551. doi: 10.1007/s12471-018-1161-x.

2.

Exposure to non-inherited maternal antigens by breastfeeding affects antibody responsiveness.

Schonewille H, van Rood JJ, Verduin EP, van de Watering LMG, Haasnoot GW, Claas FHJ, Oepkes D, Lopriore E, Brand A.

Haematologica. 2019 Feb;104(2):263-268. doi: 10.3324/haematol.2018.199406. Epub 2018 Sep 13.

3.

Recommendations on Selection and Processing of RBC Components for Pediatric Patients From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.

Zantek ND, Parker RI, van de Watering LM, Josephson CD, Bateman ST, Valentine SL, Delaney M; Pediatric Critical Care Transfusion and Anemia Expertise Initiative (TAXI); Pediatric Critical Care Blood Research Network (BloodNet), and the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network.

Pediatr Crit Care Med. 2018 Sep;19(9S Suppl 1):S163-S169. doi: 10.1097/PCC.0000000000001625.

PMID:
30161072
4.

Does a Platelet Transfusion Independently Affect Bleeding and Adverse Outcomes in Cardiac Surgery?

van Hout FM, Hogervorst EK, Rosseel PM, van der Bom JG, Bentala M, van Dorp EL, van Geloven N, Brand A, van der Meer NJ, van de Watering LM.

Anesthesiology. 2017 Mar;126(3):441-449. doi: 10.1097/ALN.0000000000001518.

PMID:
28092320
5.

The HLA-DRB1*15 phenotype is associated with multiple red blood cell and HLA antibody responsiveness.

Verduin EP, Brand A, van de Watering LM, Roelen DL, Kanhai HH, Doxiadis II, Claas FH, Schonewille H.

Transfusion. 2016 Jul;56(7):1849-56. doi: 10.1111/trf.13648. Epub 2016 May 17.

PMID:
27185287
6.

Intraoperative Anemia and Single Red Blood Cell Transfusion During Cardiac Surgery: An Assessment of Postoperative Outcome Including Patients Refusing Blood Transfusion.

Hogervorst EK, Rosseel PM, van de Watering LM, Brand A, Bentala M, van der Bom JG, van der Meer NJ.

J Cardiothorac Vasc Anesth. 2016 Apr;30(2):363-72. doi: 10.1053/j.jvca.2015.10.021. Epub 2015 Nov 2.

PMID:
26809765
7.

Factors associated with persistence of red blood cell antibodies in woman after pregnancies complicated by fetal alloimmune haemolytic disease treated with intrauterine transfusions.

Verduin EP, Brand A, van de Watering LM, Claas FH, Oepkes D, Lopriore E, Doxiadis II, Schonewille H.

Br J Haematol. 2015 Feb;168(3):443-51. doi: 10.1111/bjh.13130. Epub 2014 Sep 22.

PMID:
25244566
8.

Implementation of a new platelet pooling system for platelet concentrates led to a higher corrected count increment after transfusion: a comparative observational study of platelet concentrates before and after implementation.

Dijkstra-Tiekstra MJ, van de Watering LM, Rondeel JM, Slomp J, de Wildt-Eggen J.

Transfus Med. 2014 Apr;24(2):99-104. doi: 10.1111/tme.12105. Epub 2014 Feb 10.

PMID:
24506143
9.

Trauma hemostasis and oxygenation research position paper on remote damage control resuscitation: definitions, current practice, and knowledge gaps.

Jenkins DH, Rappold JF, Badloe JF, Berséus O, Blackbourne L, Brohi KH, Butler FK, Cap AP, Cohen MJ, Davenport R, DePasquale M, Doughty H, Glassberg E, Hervig T, Hooper TJ, Kozar R, Maegele M, Moore EE, Murdock A, Ness PM, Pati S, Rasmussen T, Sailliol A, Schreiber MA, Sunde GA, van de Watering LM, Ward KR, Weiskopf RB, White NJ, Strandenes G, Spinella PC.

Shock. 2014 May;41 Suppl 1:3-12. doi: 10.1097/SHK.0000000000000140.

10.

Observational etiologic research. Part 4--Matching in case-control studies: almost always a bad idea.

Middelburg RA, Wiersum-Osselton JC, van de Watering LM, van der Bom JG.

Transfusion. 2014 Feb;54(2):267-70. doi: 10.1111/trf.12419. Epub 2013 Sep 30. No abstract available.

PMID:
24117702
11.

Observational etiologic research: part 1--The etiologic research question: it requires DATA.

Middelburg RA, Wiersum-Osselton JC, van de Watering LM, van der Bom JG.

Transfusion. 2013 Nov;53(11):2606-8. doi: 10.1111/trf.12417. Epub 2013 Sep 30. No abstract available.

PMID:
24117626
12.

Observational etiologic research: part 2--effect measures in etiologic research.

Middelburg RA, Wiersum-Osselton JC, van de Watering LM, van der Bom JG.

Transfusion. 2013 Dec;53(12):3048-51. doi: 10.1111/trf.12416. Epub 2013 Sep 30. No abstract available.

PMID:
24117605
13.

Observational etiologic research: part 3-case-control studies: it's all about the source population.

Middelburg RA, Wiersum-Osselton JC, van de Watering LM, van der Bom JG.

Transfusion. 2014 Jan;54(1):12-6. doi: 10.1111/trf.12415. Epub 2013 Sep 30. No abstract available.

PMID:
24117524
14.

Age of blood: does older blood yield poorer outcomes?

van de Watering LM.

Curr Opin Hematol. 2013 Nov;20(6):526-32. doi: 10.1097/MOH.0b013e328365aa3a. Review.

PMID:
24104414
15.

Effects of red blood cell storage in heavily transfused patients.

van de Watering LM.

Curr Opin Anaesthesiol. 2013 Apr;26(2):204-7. doi: 10.1097/ACO.0b013e32835e7408. Review.

PMID:
23407152
16.

Storage time of red blood cells and mortality of transfusion recipients.

Middelburg RA, van de Watering LM, Briët E, van der Bom JG.

Transfus Med Rev. 2013 Jan;27(1):36-43. doi: 10.1016/j.tmrv.2012.06.002. Epub 2012 Aug 14.

PMID:
22902231
17.

Variation between hospitals in rates of reported transfusion reactions: is a high reporting rate an indicator of safer transfusion?

Wiersum-Osselton JC, van Tilborgh-de Jong AJ, Zijlker-Jansen PY, van de Watering LM, Brand A, van der Bom JG, Schipperus MR.

Vox Sang. 2013 Feb;104(2):127-34. doi: 10.1111/j.1423-0410.2012.01642.x. Epub 2012 Aug 15.

PMID:
22892067
18.

Clinical effects of leucoreduction of blood transfusions.

Bilgin YM, van de Watering LM, Brand A.

Neth J Med. 2011 Oct;69(10):441-50. Review.

19.

Storage time of blood products and transfusion-related acute lung injury.

Middelburg RA, Borkent-Raven BA, Janssen MP, van de Watering LM, Wiersum-Osselton JC, Schipperus MR, Beckers EA, Briët E, van der Bom JG.

Transfusion. 2012 Mar;52(3):658-67. doi: 10.1111/j.1537-2995.2011.03352.x. Epub 2011 Sep 26. Erratum in: Transfusion. 2012 Jun;52(6):1386. Borkent, Barbara [corrected to Borkent-Raven, Barbara A]; Jansen, Mart [corrected to Janssen, Mart P].

PMID:
21950582
20.

Comment on "Effect of storage time of transfused plasma on early and late mortality after coronary artery bypass grafting".

van der Bom JG, Middelburg RA, van de Watering LM, Brand A.

J Thorac Cardiovasc Surg. 2011 Aug;142(2):473-4. doi: 10.1016/j.jtcvs.2011.02.043. No abstract available.

21.

Postoperative complications associated with transfusion of platelets and plasma in cardiac surgery.

Bilgin YM, van de Watering LM, Versteegh MI, van Oers MH, Vamvakas EC, Brand A.

Transfusion. 2011 Dec;51(12):2603-10. doi: 10.1111/j.1537-2995.2011.03200.x. Epub 2011 Jun 3.

PMID:
21645007
22.

The effect of RBC transfusions on cytokine gene expression after cardiac surgery in patients developing post-operative multiple organ failure.

Sitniakowsky LS, Later AF, van de Watering LM, Bogaerts M, Brand A, Klautz RJ, Smit NP, van Hilten JA.

Transfus Med. 2011 Aug;21(4):236-46. doi: 10.1111/j.1365-3148.2011.01075.x. Epub 2011 Apr 24.

PMID:
21518046
23.

Sufficient-cause interaction.

van de Watering LM, Middelburg RA.

Epidemiology. 2010 Sep;21(5):753-4. doi: 10.1097/EDE.0b013e3181e942a2. No abstract available.

PMID:
20699684
24.

Blood transfusions: good or bad? Confounding by indication, an underestimated problem in clinical transfusion research.

Middelburg RA, van de Watering LM, van der Bom JG.

Transfusion. 2010 Jun;50(6):1181-3. doi: 10.1111/j.1537-2995.2010.02675.x. Epub 2010 Apr 27. Review. No abstract available.

PMID:
20456689
25.

Effects of allogeneic leukocytes in blood transfusions during cardiac surgery on inflammatory mediators and postoperative complications.

Bilgin YM, van de Watering LM, Versteegh MI, van Oers MH, Brand A.

Crit Care Med. 2010 Feb;38(2):546-52. doi: 10.1097/CCM.0b013e3181c0de7b.

PMID:
19864941
26.

Leucocyte depletion of perioperative blood transfusion does not affect long-term survival and recurrence in patients with gastrointestinal cancer.

Lange MM, van Hilten JA, van de Watering LM, Bijnen BA, Roumen RM, Putter H, Brand A, van de Velde CJ; cooperative clinical investigators of the Cancer Recurrence And Blood Transfusion (CRAB) study and the Transfusion Associated Complications = Transfusion Induced Complications? (TACTIC) study.

Br J Surg. 2009 Jul;96(7):734-40. doi: 10.1002/bjs.6636.

PMID:
19526613
27.

The clinical impact of platelet refractoriness: correlation with bleeding and survival.

Kerkhoffs JL, Eikenboom JC, van de Watering LM, van Wordragen-Vlaswinkel RJ, Wijermans PW, Brand A.

Transfusion. 2008 Sep;48(9):1959-65. doi: 10.1111/j.1537-2995.2008.01799.x. Epub 2008 Jun 28.

PMID:
18564396
28.

Effects of storage of red cells.

van de Watering LM, Brand A.

Transfus Med Hemother. 2008 Oct;35(5):359-67. doi: 10.1159/000155221. Epub 2008 Sep 18. Review.

29.

Viability does not necessarily reflect the hematopoietic progenitor cell potency of a cord blood unit: results of an interlaboratory exercise.

Brand A, Eichler H, Szczepiorkowski ZM, Hess JR, Kekomaki R, McKenna DH, Pamphilon D, Reems J, Sacher RA, Takahashi TA, van de Watering LM; Biomedical Excellence for Safer Transfusion (BEST) Collaborative.

Transfusion. 2008 Mar;48(3):546-9. Epub 2007 Dec 7.

PMID:
18067495
30.

Is increased mortality associated with post-operative infections after leukocytes containing red blood cell transfusions in cardiac surgery? An extended analysis.

Bilgin YM, van de Watering LM, Eijsman L, Versteegh MI, van Oers MH, Brand A.

Transfus Med. 2007 Aug;17(4):304-11.

PMID:
17680957
31.

High additional maternal red cell alloimmunization after Rhesus- and K-matched intrauterine intravascular transfusions for hemolytic disease of the fetus.

Schonewille H, Klumper FJ, van de Watering LM, Kanhai HH, Brand A.

Am J Obstet Gynecol. 2007 Feb;196(2):143.e1-6.

PMID:
17306657
32.

Prevalence of HLA antibodies in transfused patients with and without red blood cell antibodies.

Schonewille H, van de Watering LM.

Transfusion. 2007 Feb;47(2):357-8; author reply 358. No abstract available.

PMID:
17302788
33.
34.

Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity.

Schonewille H, van de Watering LM, Loomans DS, Brand A.

Transfusion. 2006 Feb;46(2):250-6.

PMID:
16441603
35.

Cost-effectiveness of leucocyte-depleted erythrocyte transfusion in cardiac valve surgery.

van Hulst M, Bilgin YM, van de Watering LM, de Vries R, van Oers MH, Brand A, Postma MJ.

Transfus Med. 2005 Jun;15(3):209-17.

PMID:
15943705
36.

Double-blind, randomized controlled trial on the effect of leukocyte-depleted erythrocyte transfusions in cardiac valve surgery.

Bilgin YM, van de Watering LM, Eijsman L, Versteegh MI, Brand R, van Oers MH, Brand A.

Circulation. 2004 Jun 8;109(22):2755-60. Epub 2004 May 17.

PMID:
15148271
37.

Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery.

van Hilten JA, van de Watering LM, van Bockel JH, van de Velde CJ, Kievit J, Brand R, van den Hout WB, Geelkerken RH, Roumen RM, Wesselink RM, Koopman-van Gemert AW, Koning J, Brand A.

BMJ. 2004 May 29;328(7451):1281. Epub 2004 May 13.

38.

Cost-effectiveness of leucocyte depletion of red-cell transfusions for patients undergoing cardiac surgery.

Postma MJ, van de Watering LM, de Vries R, Versmoren D, van Hulst M, Tobi H, van der Poel CL, Brand A.

Vox Sang. 2003 Jan;84(1):65-7. No abstract available.

PMID:
12542735
39.

Perioperative blood transfusions, with or without allogeneic leucocytes, relate to survival, not to cancer recurrence.

van de Watering LM, Brand A, Houbiers JG, Klein Kranenbarg WM, Hermans J, van de Velde C; Cancer Recurrence and Blood transfusion study group.

Br J Surg. 2001 Feb;88(2):267-72.

PMID:
11167879
40.

Clinical significance of leukoreduktion of blood components.

Brand A, van de Watering LM, Claas FH.

Vox Sang. 2000;78 Suppl 2:227-9. Review.

PMID:
10938958
41.

Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial.

van de Watering LM, Hermans J, Houbiers JG, van den Broek PJ, Bouter H, Boer F, Harvey MS, Huysmans HA, Brand A.

Circulation. 1998 Feb 17;97(6):562-8.

PMID:
9494026
42.

Transfusion of red cells is associated with increased incidence of bacterial infection after colorectal surgery: a prospective study.

Houbiers JG, van de Velde CJ, van de Watering LM, Hermans J, Schreuder S, Bijnen AB, Pahlplatz P, Schattenkerk ME, Wobbes T, de Vries JE, Klementschitsch P, van de Maas AH, Brand A.

Transfusion. 1997 Feb;37(2):126-34.

PMID:
9051085
43.

Postoperative infection after colorectal surgery.

Houbiers JG, van de Watering LM, van de Velde CH, Brand A.

Lancet. 1996 Dec 14;348(9042):1665-6. No abstract available.

PMID:
8962018
44.

Antibodies against p53 are associated with poor prognosis of colorectal cancer.

Houbiers JG, van der Burg SH, van de Watering LM, Tollenaar RA, Brand A, van de Velde CJ, Melief CJ.

Br J Cancer. 1995 Sep;72(3):637-41.

45.

Blood transfusion in cancer surgery: a consensus statement.

Houbiers JG, Busch OR, Van de Watering LM, Marquet RL, Brand A, Jeekel H, Van de Velde CJ.

Eur J Surg. 1995 May;161(5):307-14. Review. No abstract available.

PMID:
7662772
46.

Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer.

Houbiers JG, Brand A, van de Watering LM, Hermans J, Verwey PJ, Bijnen AB, Pahlplatz P, Eeftinck Schattenkerk M, Wobbes T, de Vries JE, et al.

Lancet. 1994 Aug 27;344(8922):573-8.

PMID:
7914960
47.

Autologous blood and infections after colorectal surgery.

Houbiers JG, van de Watering LM, van de Velde CJ, Brand A.

Lancet. 1994 Mar 12;343(8898):668; author reply 668-9. No abstract available.

PMID:
7906823

Supplemental Content

Loading ...
Support Center